These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 9693398

  • 21. The effects of reformulated 2-rod Norplant implant on hemostasis after three years.
    Viegas OA, Koh SC, Ratnam SS.
    Contraception; 1996 Oct; 54(4):219-28. PubMed ID: 8922875
    [Abstract] [Full Text] [Related]

  • 22. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J, Middeldorp S, Curvers J, Christella M, Thomassen LG, Nicolaes GA, Meijers JC, Bouma BN, Büller HR, Prins MH, Tans G.
    Lancet; 1999 Dec 11; 354(9195):2036-40. PubMed ID: 10636369
    [Abstract] [Full Text] [Related]

  • 23. Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over.
    Mackie IJ, Piegsa K, Furs SA, Johnson J, Bounds W, Machin SJ, Guillebaud J.
    Br J Haematol; 2001 Jun 11; 113(4):898-904. PubMed ID: 11442481
    [Abstract] [Full Text] [Related]

  • 24. [Hemostatic balance during treatment with the newest contraceptives].
    Petersen KR, Skouby SO, Sidelmann J, Jespersen J.
    Ugeskr Laeger; 1994 Jan 10; 156(2):187-90. PubMed ID: 8296409
    [Abstract] [Full Text] [Related]

  • 25. Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. A double-blind, randomised study.
    Gaussem P, Alhenc-Gelas M, Thomas JL, Bachelot-Loza C, Remones V, Ali FD, Aiach M, Scarabin PY.
    Thromb Haemost; 2011 Mar 10; 105(3):560-7. PubMed ID: 21225090
    [Abstract] [Full Text] [Related]

  • 26. The effects of two progestogen-only pills containing either desogestrel (75 microg/day) or levonorgestrel (30 microg/day) on lipid metabolism.
    Barkfeldt J, Virkkunen A, Dieben T.
    Contraception; 2001 Nov 10; 64(5):295-9. PubMed ID: 11777489
    [Abstract] [Full Text] [Related]

  • 27. Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII.
    van Rooijen M, von Schoultz B, Silveira A, Hamsten A, Bremme K.
    Am J Obstet Gynecol; 2002 Jan 10; 186(1):44-8. PubMed ID: 11810082
    [Abstract] [Full Text] [Related]

  • 28. Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.
    Anawalt BD, Herbst KL, Matsumoto AM, Mulders TM, Coelingh-Bennink HJ, Bremner WJ.
    Fertil Steril; 2000 Oct 10; 74(4):707-14. PubMed ID: 11020511
    [Abstract] [Full Text] [Related]

  • 29. Oral contraceptives and blood coagulation.
    Bonnar J, Sabra AM.
    J Reprod Med; 1986 Jun 10; 31(6 Suppl):551-6. PubMed ID: 2941571
    [Abstract] [Full Text] [Related]

  • 30. A prospective study on the effects on hemostasis of two oral contraceptives containing drospirenone in combination with either 30 or 20 microg ethinyl estradiol and a reference containing desogestrel and 30 microg ethinyl estradiol.
    Kluft C, Endrikat J, Mulder SM, Gerlinger C, Heithecker R.
    Contraception; 2006 Apr 10; 73(4):336-43. PubMed ID: 16531162
    [Abstract] [Full Text] [Related]

  • 31. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
    Gaspard UJ, Buret J, Gillain D, Romus MA, Lambotte R.
    Contraception; 1985 Apr 10; 31(4):395-408. PubMed ID: 3159546
    [Abstract] [Full Text] [Related]

  • 32. Hemostasis profile in women taking low-dose oral contraceptives.
    David JL, Gaspard UJ, Gillain D, Raskinet R, Lepot MR.
    Am J Obstet Gynecol; 1990 Jul 10; 163(1 Pt 2):420-3. PubMed ID: 2142579
    [Abstract] [Full Text] [Related]

  • 33. A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel.
    Winkler UH, Daume E, Sudik R, Oberhoff C, Bier U, Hallmann C, Andreas JO, Schindler AE.
    Eur J Contracept Reprod Health Care; 1999 Sep 10; 4(3):145-54. PubMed ID: 10574640
    [Abstract] [Full Text] [Related]

  • 34. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
    Sabra A, Bonnar J.
    J Reprod Med; 1983 Jan 10; 28(1 Suppl):85-91. PubMed ID: 6834350
    [Abstract] [Full Text] [Related]

  • 35. Seventy-five microgram desogestrel minipill, a new perspective in estrogen-free contraception.
    Benagiano G, Primiero FM.
    Ann N Y Acad Sci; 2003 Nov 10; 997():163-73. PubMed ID: 14644823
    [Abstract] [Full Text] [Related]

  • 36. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
    Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, Bouma BN, Büller HR, Rosing J.
    Thromb Haemost; 2000 Jul 10; 84(1):15-21. PubMed ID: 10928463
    [Abstract] [Full Text] [Related]

  • 37. The effects of a low-dose monophasic preparation of levonorgestrel and ethinyl estradiol on coagulation and other hemostatic factors.
    Archer DF, Mammen EF, Grubb GS.
    Am J Obstet Gynecol; 1999 Nov 10; 181(5 Pt 2):63-6. PubMed ID: 10561678
    [Abstract] [Full Text] [Related]

  • 38. A comparison of the inhibition of ovulation achieved by desogestrel 75 micrograms and levonorgestrel 30 micrograms daily.
    Rice CF, Killick SR, Dieben T, Coelingh Bennink H.
    Hum Reprod; 1999 Apr 10; 14(4):982-5. PubMed ID: 10221231
    [Abstract] [Full Text] [Related]

  • 39. An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol/2 mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables.
    Winkler UH, Röhm P, Höschen K.
    Contraception; 2010 May 10; 81(5):391-400. PubMed ID: 20399945
    [Abstract] [Full Text] [Related]

  • 40. The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
    Lewis MA, Heinemann LA, MacRae KD, Bruppacher R, Spitzer WO.
    Contraception; 1996 Jul 10; 54(1):5-13. PubMed ID: 8804801
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.